Cogstate Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other
companies in this sector in Australia:
Clinuvel Pharmaceuticals Limited
sales of 25.75 million Australian Dollars [US$18.26 million]
of which 100%
Xrf Scientific Ltd
(24.25 million Australian Dollars [US$17.20 million]
of which 42%
was Precious Metals), and
(50.33 million Australian Dollars [US$35.70 million]
During the year ended June of 2018, sales at
Cogstate Ltd were A$37.49 million (US$26.59 million).
increase of 7.1%
versus 2017, when the company's sales were A$35.02 million.
This was the fourth straight year of sales growth at Cogstate Ltd.
Sales of Adminstration (Including Reserch) saw an increase
that was more than double the company's growth rate: sales were up
3,713.0% in 2018, from
A$16,674.00 to A$635,787.18 .
Cogstate Ltd also saw significant increases in sales in
Healthcare (Inluding Concussion Manageme (up 82.4% to A$497,659.31 )